Regulus Therapeutics Inc(NASDAQ:RGLS) 
Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that target microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in clinical trial for the trea...
Website: http://www.regulusrx.com
Founded: 2007
Full Time Employees: 24
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-12-23
P
O 1.57
H 1.59
L 1.49
C 1.53
V 309,837
10EMA 1.53
20EMA 1.53
60EMA 1.53
120EMA 1.53
250EMA 1.53